Market Place
Sourcing Support
23andMe Unveils First-of-Its-Kind Ancestor DNA Discovery Tool
13 Mar 2026 //
GLOBENEWSWIRE
23AndMe Research Institute Appoints John Mcleod General Counsel
09 Dec 2025 //
GLOBENEWSWIRE
23AndMe Research Institute Appoints Kael Reicin as CFO
05 Nov 2025 //
GLOBENEWSWIRE
23andMe Research Institute Appoints Privacy Advisory Board
30 Oct 2025 //
GLOBENEWSWIRE
23andMe Seeks Approval of Larger, $50M Data Breach Settlement
06 Sep 2025 //
REUTERS
23andMe seeks New Bids After $305M offer from its co-founder
05 Jun 2025 //
REUTERS
Consumers urged to delete 23andMe data as bankruptcy sparks
26 Mar 2025 //
REUTERS
Anne Wojcicki steps down to bid on 23andMe’s bankruptcy auction
24 Mar 2025 //
FIERCE BIOTECH
23andMe Board Rejects CEO Anne Wojcicki`s Buyout Proposal
03 Mar 2025 //
GLOBENEWSWIRE
Independent Directors of 23andMe Resign from Board
17 Sep 2024 //
GLOBENEWSWIRE
23andMe settles data breach lawsuit for $30 million
14 Sep 2024 //
REUTERS
Large Study Reveals Sickle Cell Trait And Blood Clot Link
12 Sep 2024 //
GLOBENEWSWIRE
23andMe CEO Open To Third-Party Takeover Proposals, Filing Shows
11 Sep 2024 //
REUTERS
Lemonaid Health Offers GLP-1 Medication In Weight Loss Program
28 Aug 2024 //
GLOBENEWSWIRE
Genetic testing firm 23andMe rejects CEO`s take-private offer
02 Aug 2024 //
REUTERS
23andMe Announces CEO’s Take-Private Proposal
01 Aug 2024 //
GLOBENEWSWIRE
Lung Cancer Advocacy Groups And 23andMe Launch Genetics Study
25 Jul 2024 //
GLOBENEWSWIRE
23andMe to Report Q1 FY2025 Financial Results
25 Jul 2024 //
GLOBENEWSWIRE
Largest LRRK2 Study Reveals Health, Ancestry, History Insights
29 May 2024 //
GLOBENEWSWIRE
23andMe to Present Data at AACR Annual Meeting 2024
05 Apr 2024 //
GLOBENEWSWIRE
23andMe Launches New Genetic Reports on Common Forms of Cancer
06 Mar 2024 //
GLOBENEWSWIRE
23andMe Announces Presentations from Clinical-Stage Immuno-Oncology Programs
05 Mar 2024 //
GLOBENEWSWIRE
23andMe Launches Month-Long Initiative to Amplify ARRAY’s “Seat16” Program
30 Jan 2024 //
GLOBENEWSWIRE
23andMe Launches Total Health, its Prevention-Based Health Membership
07 Nov 2023 //
GLOBENEWSWIRE
23andMe Launches Action Plan to Provide Recommendations Based on Genetic Data
31 Oct 2023 //
GLOBENEWSWIRE
23andMe Announces Collaboration Extension with Data Licensing Agreement with GSK
30 Oct 2023 //
GLOBENEWSWIRE
23andMe and Sickle Cell 101 Collaborate to Expand Sickle Cell Awareness Program
14 Sep 2023 //
GLOBENEWSWIRE
23andMe Granted New FDA Clearance to Report Additional BRCA Variants
31 Aug 2023 //
GLOBENEWSWIRE
23andMe Reports FY2024 First Quarter Financial Results
08 Aug 2023 //
GLOBENEWSWIRE
23andMe Releases New FDA-Cleared Genetic Report on Simvastatin
20 Jul 2023 //
GLOBENEWSWIRE
23andMe Reports FY2023 Fourth Quarter and Full Year Financial Results
25 May 2023 //
GLOBENEWSWIRE
23andMe Releases New Report Revealing Likelihood of Developing Lupus
09 May 2023 //
GLOBENEWSWIRE
Reza Afkhami Joins 23andMe as Chief Corporate Development Officer
08 May 2023 //
GLOBENEWSWIRE
23andMe to Present at Upcoming Investor Conferences
22 Feb 2023 //
GLOBENEWSWIRE
23andMe Reports FY2023 Third Quarter Financial Results
08 Feb 2023 //
GLOBENEWSWIRE
23andMe to Report FY2023 Third Quarter Financial Results
26 Jan 2023 //
GLOBENEWSWIRE
23andMe Trials-in-Progress Poster Details Expansion Cohorts for 23ME-00610
07 Nov 2022 //
GLOBENEWSWIRE
23andMe to Report FY2023 Second Quarter Financial Results
24 Oct 2022 //
GLOBENEWSWIRE
23andMe to Present at Upcoming Investor Conferences
12 Oct 2022 //
GLOBENEWSWIRE
23andMe Announces Trials-in-Progress Poster Presentation on 23ME-00610
05 Oct 2022 //
GLOBENEWSWIRE
23andMe Reports FY2023 First Quarter Financial Results
08 Aug 2022 //
GLOBENEWSWIRE
23andMe to Report FY2023 First Quarter Financial Results
25 Jul 2022 //
GLOBENEWSWIRE
23andMe posts $217M net loss during `transitional` fiscal year
31 May 2022 //
MOBIHEALTHNEWS
23andMe Reports FY2022 Fourth Quarter and Full Year Financial Results
26 May 2022 //
GLOBENEWSWIRE
23andMe to Report FY2022 Fourth Quarter and Full Year Financial Results
12 May 2022 //
GLOBENEWSWIRE
23andMe to Present at AACR (AACR) 2022
15 Mar 2022 //
GLOBENEWSWIRE
23andMe to Present at Cowen 42nd Annual Health Care Conference
25 Feb 2022 //
GLOBENEWSWIRE
Hal Barron keeps 23andMe close on GSK`s side to find more genes
19 Jan 2022 //
ENDPTS
23andMe snags 3rd FDA nod for genetic cancer risk test
10 Jan 2022 //
FIERCEBIOTECH
23andMe Initiates Phase 1 Trial for 1st Wholly-Owned Immuno-oncology Antibody
06 Jan 2022 //
GLOBENEWSWIRE
23andMe Announces Redemption of All Outstanding Warrants
22 Nov 2021 //
GLOBENEWSWIRE
23andMe Announces the Closing of its Acquisition of Lemonaid Health
01 Nov 2021 //
GLOBENEWSWIRE
23andMe Agrees to Acquire Lemonaid Health
22 Oct 2021 //
BIOSPACE
23andMe Reports FY2022 First Quarter Financial Results
13 Aug 2021 //
GLOBENEWS WIRE
Industry Leaders Join 23andMe Board of Directors
21 Jun 2021 //
GLOBENEWSWIRE
23andMe rises in first trade after Richard Branson SPAC merger
18 Jun 2021 //
CNBC
23andMe Successfully Closes its Business Combination with VG Acquisition
16 Jun 2021 //
BIOSPACE
SPAC VG Acquisition gains after shareholders approve 23andMe deal (update)
10 Jun 2021 //
SEEKING ALPHA
Moderna gets the OK to use vaccine in children ages 12-17
07 Jun 2021 //
ENDPTS
